Biotech news
Pharma
A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue. 30 May 2023
Pharma
Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents. 25 May 2023
Pharma
Despite one judge’s insistence that the case was “narrow and fact dependent”, GSK v Teva could have wide-reaching implications for generic drugs, biosimilars, and how skinny labels are read, say Chad Landmon, Ross Blau, Gulrukh Haroon of Axinn, Veltrop & Harkrider. 23 May 2023
Africa
Government-led schemes to incentivise patents are leading to delays and prejudice against legitimate applicants. Tyron Grant of Spoor and Fisher explains how South Africa is tackling the problem. 9 May 2023
Americas
Lawsuit concerns multibillion-dollar bone-strengthening drugs |
Alleged dearth of information provided to patent owner before biologics licence application was approved. 4 May 2023
Americas
Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x. 4 May 2023
Pharma
Proposals include new regulatory protection periods for innovative drugs | Changes are aimed at improving patient access to therapeutics and boosting the EU pharma industry. 27 April 2023
Americas
Biotech fails to convince Federal Circuit to overturn PTAB finding | Invalidation of patent related to “Non-liposomal systems for nucleic acid delivery”. 12 April 2023
Biotech
Arbutus and Genevant claims Pfizer/BioNTech vaccine uses patented technology | Claim follows last year’s lawsuit against Moderna. 6 April 2023
Biotech
Recruit from DLA Piper brings two decades of patent and technical experience in life sciences, biotechnology, and healthcare industries. 28 March 2023